Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET DysregulationsDigestive System Diseases, Digestive System Neoplasms, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, cancer, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gastric cancer, gastric neoplasm, glioma, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor, sarcoma, stomach disorderRecruitingPhase 2 / Phase 32025-11-24NCT06988475

5 results · Page 1 of 1

Swipe the table sideways for more columns.

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Addenbrooke's HospitalCambridgeUnited Kingdom8
Belfast City HospitalBelfastUnited Kingdom24
Bristol Haematology and Oncology CentreBristolUnited Kingdom26
Churchill HospitalOxfordUnited Kingdom43
Clatterbridge Cancer CentreMetropolitan Borough of WirralUnited Kingdom14
Freeman HospitalNewcastleUnited Kingdom14
Guy's HospitalLondonUnited Kingdom44
Leicester Royal InfirmaryLeicesterUnited Kingdom35
Royal Marsden HospitalSuttonUnited Kingdom29
Southampton General HospitalSouthamptonUnited Kingdom56
The Beatson HospitalGlasgowUnited Kingdom8
The Christie HospitalManchesterUnited Kingdom27
University College London HospitalLondonUnited Kingdom20
University Hospital BirminghamBirminghamUnited Kingdom8
Velindre Cancer CentreCardiffUnited Kingdom32
Western General HospitalEdinburghUnited Kingdom52
Western Park HospitalSheffieldUnited Kingdom1